Detalhe da pesquisa
1.
Increasing age is not associated with toxicity leading to discontinuation of treatment in patients with urothelial non-muscle-invasive bladder cancer randomised to receive 3 years of maintenance bacille Calmette-Guérin: results from European Organisation for Research and Treatment of Cancer Genito-Urinary Group study 30911.
BJU Int
; 118(3): 423-8, 2016 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26945890
2.
Molecular and clinical support for a four-tiered grading system for bladder cancer based on the WHO 1973 and 2004 classifications.
Mod Pathol
; 28(5): 695-705, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25431236
3.
Controversies in the treatment of high-risk prostate cancer--what is the optimal combination of hormonal therapy and radiotherapy: a review of literature.
Prostate
; 70(7): 701-9, 2010 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20017166
4.
The development of multiple bladder tumour recurrences in relation to the FGFR3 mutation status of the primary tumour.
J Pathol
; 218(1): 104-12, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19156776
5.
Patients' perceived burden of cystoscopic and urinary surveillance of bladder cancer: a randomized comparison.
BJU Int
; 101(9): 1106-10, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-17888042
6.
Pelvic exenteration for primary and recurrent gynaecological malignancies.
Eur J Obstet Gynecol Reprod Biol
; 134(2): 243-8, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16950559
7.
FGFR3 and P53 characterize alternative genetic pathways in the pathogenesis of urothelial cell carcinoma.
Cancer Res
; 64(6): 1911-4, 2004 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15026322
8.
Stem cell factor receptor (c-KIT) codon 816 mutations predict development of bilateral testicular germ-cell tumors.
Cancer Res
; 63(22): 7674-8, 2003 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-14633689
9.
EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non-Muscle-invasive Stage Ta-T1 Urothelial Bladder Cancer Patients Treated with 1-3 Years of Maintenance Bacillus Calmette-Guérin.
Eur Urol
; 69(1): 60-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26210894
10.
Molecular grading of urothelial cell carcinoma with fibroblast growth factor receptor 3 and MIB-1 is superior to pathologic grade for the prediction of clinical outcome.
J Clin Oncol
; 21(10): 1912-21, 2003 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-12743143
11.
Combined microsatellite and FGFR3 mutation analysis enables a highly sensitive detection of urothelial cell carcinoma in voided urine.
Clin Cancer Res
; 9(1): 257-63, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12538478
12.
Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancer.
Radiother Oncol
; 117(2): 252-7, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26409832
13.
Bladder function preservation with brachytherapy, external beam radiation therapy, and limited surgery in bladder cancer patients: Long-term results [corrected].
Int J Radiat Oncol Biol Phys
; 88(3): 611-7, 2014 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24411629
14.
The effect of age on the efficacy of maintenance bacillus Calmette-Guérin relative to maintenance epirubicin in patients with stage Ta T1 urothelial bladder cancer: results from EORTC genito-urinary group study 30911.
Eur Urol
; 66(4): 694-701, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24948466
15.
Screening for prostate cancer: results of the Rotterdam section of the European randomized study of screening for prostate cancer.
Eur Urol
; 64(4): 530-9, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23759326
16.
Markers predicting response to bacillus Calmette-Guérin immunotherapy in high-risk bladder cancer patients: a systematic review.
Eur Urol
; 61(1): 128-45, 2012 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-22000498
17.
High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: a 7-year experience.
Int J Radiat Oncol Biol Phys
; 83(5): 1480-5, 2012 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22285661
18.
CyberKnife stereotactic radiotherapy as monotherapy for low- to intermediate-stage prostate cancer: early experience, feasibility, and tolerance.
J Endourol
; 24(5): 865-9, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20433370
19.
The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading.
Eur Urol
; 57(6): 1052-7, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19765886
20.
Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Guérin, and bacillus Calmette-Guérin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder.
Eur Urol
; 57(5): 766-73, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20034729